Lista de obras - Yasuhiro Kobayashi - Dominio Público Uruguay

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro

artículo científico publicado en 2017

Action of RANKL and OPG for osteoclastogenesis.

artículo científico publicado en 2009

Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice

artículo científico publicado en 2010

Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways

artículo científico publicado en 2014

Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts

artículo científico publicado en 2017

Cell adhesion is a prerequisite for osteoclast survival

artículo científico publicado en 2000

Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks

artículo científico publicado en 2006

DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.

artículo científico publicado en 2015

Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone

artículo científico publicado en 2012

Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.

artículo científico publicado en 2009

Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners

artículo científico publicado en 2008

Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts.

artículo científico publicado en 1998

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment

article

Identification of cell cycle-arrested quiescent osteoclast precursors in vivo

artículo científico publicado en 2009

Identification of embryonic precursor cells that differentiate into thymic epithelial cells expressing autoimmune regulator

artículo científico publicado en 2016

Identification of osteoclasts in culture

artículo científico publicado en 2011

Lineage-committed osteoclast precursors circulate in blood and settle down into bone

artículo científico publicado en 2011

Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization

artículo científico publicado en 2015

MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts

artículo científico publicado en 2007

Multiwalled carbon nanotubes specifically inhibit osteoclast differentiation and function

artículo científico publicado en 2009

Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts

scientific article published on 26 July 2018

Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis.

artículo científico

Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy

artículo científico publicado en 2017

Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption ⬇️

artículo científico publicado el 18 de septiembre de 2003

Osteoprotegerin-Deficient Male Mice as a Model for Severe Alveolar Bone Loss: Comparison With RANKL-Overexpressing Transgenic Male Mice ⬇️

artículo científico publicado el 4 de enero de 2013

Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals

artículo científico publicado en 2017

Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.

artículo científico publicado en 2011

Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.

artículo científico publicado en 2005

Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors

artículo científico publicado en 2005

Prostaglandin E2 strongly inhibits human osteoclast formation

artículo científico publicado en 2005

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

artículo científico publicado en 2000

Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling

artículo científico publicado en 2017

Regulation of bone metabolism by Wnt signals

artículo científico

Roles of Wnt signaling in bone formation and resorption

Roles of Wnt signals in bone resorption during physiological and pathological states.

artículo científico

Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis.

artículo científico publicado en 2013

Specification of tissue-resident macrophages during organogenesis.

artículo científico publicado en 2016

Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice

artículo científico publicado en 2012

Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur

scientific article published on 01 December 1998

Systemic circulation and bone recruitment of osteoclast precursors tracked by using fluorescent imaging techniques

artículo científico publicado en 2012

Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.

artículo científico publicado en 2012

The HIV co-receptor CCR5 regulates osteoclast function.

artículo científico publicado en 2017

The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway

scientific article published on 09 July 2019

The Regulation of Bone Metabolism and Disorders by Wnt Signaling

scientific article published on 06 November 2019

The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts

artículo científico publicado en 2015

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

artículo científico publicado en 2017

Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways

artículo científico publicado en 2015

Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.

artículo científico publicado en 2015

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis

artículo científico publicado en 2012

p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages

artículo científico publicado en 2003

Lista de obras de Yasuhiro Kobayashi

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro

Action of RANKL and OPG for osteoclastogenesis.

Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice

Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways

Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts

Cell adhesion is a prerequisite for osteoclast survival

Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks

DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.

Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone

Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.

Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners

Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts.

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment

Identification of cell cycle-arrested quiescent osteoclast precursors in vivo

Identification of embryonic precursor cells that differentiate into thymic epithelial cells expressing autoimmune regulator

Identification of osteoclasts in culture

Lineage-committed osteoclast precursors circulate in blood and settle down into bone

Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization

MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts

Multiwalled carbon nanotubes specifically inhibit osteoclast differentiation and function

Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts

Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis.

Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy

Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption ⬇️

Osteoprotegerin-Deficient Male Mice as a Model for Severe Alveolar Bone Loss: Comparison With RANKL-Overexpressing Transgenic Male Mice ⬇️

Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals

Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.

Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.

Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors

Prostaglandin E2 strongly inhibits human osteoclast formation

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling

Regulation of bone metabolism by Wnt signals

Roles of Wnt signaling in bone formation and resorption

Roles of Wnt signals in bone resorption during physiological and pathological states.

Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis.

Specification of tissue-resident macrophages during organogenesis.

Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice

Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur

Systemic circulation and bone recruitment of osteoclast precursors tracked by using fluorescent imaging techniques

Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.

The HIV co-receptor CCR5 regulates osteoclast function.

The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway

The Regulation of Bone Metabolism and Disorders by Wnt Signaling

The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways

Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis

p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages